Why Abzena?
Our focused approach.
Ensuring compliance and a robust regulatory strategy, we develop phase-appropriate qualification, characterization, and analytical method validation strategies appropriate to your stage of product development and assist in the preparation of global filings.
We offer consolidated phase-appropriate validation packages with fit-for-purpose methods and robust de novo assays that stand up to regulatory scrutiny.
Ensuring conformance with ICHQ7, our scientists ensure cGMP compliance and the highest levels of efficiency without compromising product quality or patient safety.
Based on our decades of regulatory experience, we will provide the best strategy for your molecule, regardless of its phase. We are here to support all your regulatory needs.
Ensuring the robustness and repeatability of your process and consistent quality of product, we utilize design of experiment (DOE) studies to ensure your process is fully understood and documented to support successful regulatory submissions.
Saving time and ensuring scalability, we are committed to quality excellence and designing and delivering tailored solutions with patient safety in mind.
Our team has expansive experience and capability to consider your process requirements, developing a series of protocols and regulatory strategies tailored to your molecule and desired function.
Helping you meet regulatory and quality requirements, our experts provide guidance and design; execute; and document analytical method development, qualification, and validation programs to support even your most complex molecules.
Ensuring compliance throughout, we follow ICHQ2(R2) guidelines for method validation, delivering robust programs that meet your requirements.
The asset you’re developing right now can make a real difference for human health. Let us apply our wealth of experience to accelerate and maximize its potential.